AU2006231212B2 — An ultrasonically detectable intrauterine system and a method for enhancing ultrasound detection
Assigned to Bayer Oy · Expires 2011-10-06 · 15y expired
What this patent protects
The present invention relates to ultrasonically detectable intrauterine systems and to a method for enhancing ultrasound detection of these systems. An intrauterine sys- tem having an inert metal coating on at least part of the body of the intrauterine system or at least one iner…
USPTO Abstract
The present invention relates to ultrasonically detectable intrauterine systems and to a method for enhancing ultrasound detection of these systems. An intrauterine sys- tem having an inert metal coating on at least part of the body of the intrauterine system or at least one inert metal clip, pin, ring or sleeve fixedly positioned on the body of the intrauterine system is described.
Drugs covered by this patent
- Jadelle (LEVONORGESTREL) · Fdn Consumer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.